Advocacy. Education. Action. That’s the name of the game at the Time in Range Coalition.
In just a few years, we’ve been able to improve the quality of life for an astonishing number of people with diabetes—we’ve reached close to a million people through our work already.
So, how are we able to help so many people? Great question, we’re glad you asked.
Since forming the Coalition in 2020, we’ve spurred a movement made up of people who are learning about the benefits of time in range. Through research, outreach, and action, we’ve been able to make time in range more accessible and increase adoption for people with diabetes and those who care for them. That’s a pretty big win.
We’re fighting to make sure that information, resources, and CGM metrics are easy to access, easier to understand, and more accessible as a tool to empower every day management of diabetes. We’re making the change that we want to see.
We’re inspired by the progress we’ve made and the positive impact it’s having. When people know more about their blood glucose and how it’s affecting their bodies, they can do more. All that to say, we’re not done yet!
Here are some of the big milestones we’ve seen over the past few years—we can’t wait to see what else we can do together.
- We established the norm for using CGMs in all relevant clinical trials in the world by helping publish “Continuous Glucose Monitoring (CGM) Metrics for Clinical Trials: An International Consensus” in The Lancet. In partnership with 33 leading diabetes experts, this will push forward advances in CGM use and diabetes care! The consensus has been cited over 200 times to date.
- We’re working with the European Diabetes Forum (EUDF) and the International Diabetes Federation (IDF) to extend the use of time in range as a key metric in diabetes management worldwide.
- We’re continuously engaging with global regulatory agencies like the FDA (U.S. Food & Drug Administration) and the EMA (European Medicines Agency) to push forward widespread acceptance of time in range as a primary endpoint, and ensure that regulatory practices are up to date with real-world clinical practices.
- We’ve conducted real-world research on the insights and benefits of Time in Range and shared our findings at the biggest diabetes research conferences in the world: The Advanced Technologies & Treatments for Diabetes, American Diabetes Association, Association of Diabetes Care and Education Specialists, and European Association for the Study of Diabetes.
- We’ve partnered with some of the leading healthcare education organizations to spread awareness and resources with primary care providers across the country, so that every person with diabetes, even if they’re not seeing a specialist, has access and education opportunities to time in range.
- We uplift and prominently feature the voices of real people with diabetes to ensure that we’re not just speaking to the diabetes community, but that we’re sparking a conversation between the people who are living day to day with diabetes.